BUCHI J KEVIN — SEC insider filings

SEC reporting owner CIK 1209726. 31 insider filings on record with FilingPulse; latest filed 2026-09-21.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2020-10-13 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ampio Pharmaceuticals, Inc. (AMPE)Director65 legs · 146,858 sh · $38,978—2
Benitec Biopharma Inc. (BNTC)Director101 leg · 51,813 sh—12
Amneal Pharmaceuticals, Inc. (AMRX)Director11——23
Dicerna Pharmaceuticals Inc (DRNA)Director2——11
ZIOPHARM ONCOLOGY INC (ZIOP)Director2——3

Insider filings — BUCHI J KEVIN

FiledFormIssuerReported transactionsSource
2026-09-214Amneal Pharmaceuticals, Inc. (AMRX)Gift (G): 20,445 @ $0EDGAR
2026-09-144Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 20,445 @ $14.45 · Option exercise (M): 20,445 (derivative) @ $0EDGAR
2026-08-134Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 168,573 @ $17.18EDGAR
2026-06-304Benitec Biopharma Inc. (BNTC)Gift (G): 51,813 @ $0EDGAR
2026-05-084Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 34,819 · Option exercise (M): 34,819 (derivative) @ $0 · Grant/award (A): 19,824 (derivative) @ $0EDGAR
2025-12-034Benitec Biopharma Inc. (BNTC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2025-05-084Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 40,258 · Option exercise (M): 40,258 (derivative) @ $0 · Grant/award (A): 34,819 (derivative) @ $0EDGAR
2025-03-134Benitec Biopharma Inc. (BNTC)Gift (G): 103,626 @ $0 · Gift (G): 103,626 @ $0EDGAR
2025-03-124Amneal Pharmaceuticals, Inc. (AMRX)Gift (G): 262,072 @ $0EDGAR
2025-03-034Benitec Biopharma Inc. (BNTC)Option exercise (M): 51,813 @ $3.86 · Option exercise (M): 51,813 (derivative) @ $0EDGAR
2024-12-114Benitec Biopharma Inc. (BNTC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-05-144Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 76,453 · Option exercise (M): 76,453 (derivative) @ $0EDGAR
2024-05-064Amneal Pharmaceuticals, Inc. (AMRX)Grant/award (A): 40,258 (derivative) @ $0EDGAR
2023-12-074Benitec Biopharma Inc. (BNTC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2023-08-144Benitec Biopharma Inc. (BNTC)Purchase (P): 51,813 · Purchase (P): 51,813 (derivative)EDGAR
2023-06-134Ampio Pharmaceuticals, Inc. (AMPE)Purchase (P): 21,858 @ $0.29EDGAR
2023-06-094Ampio Pharmaceuticals, Inc. (AMPE)Purchase (P): 25,000 @ $0.30EDGAR
2023-05-174Ampio Pharmaceuticals, Inc. (AMPE)Purchase (P): 32,534 @ $0.27EDGAR
2023-05-164Ampio Pharmaceuticals, Inc. (AMPE)Purchase (P): 23,440 @ $0.24 · Purchase (P): 44,026 @ $0.25EDGAR
2023-05-114Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 80,128 · Grant/award (A): 76,453 (derivative) @ $0 · Option exercise (M): 80,128 (derivative) @ $0EDGAR
2022-12-094Benitec Biopharma Inc. (BNTC)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-05-104Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 35,406 · Option exercise (M): 35,406 (derivative) @ $0 · Grant/award (A): 80,128 (derivative) @ $0EDGAR
2022-01-034Ampio Pharmaceuticals, Inc. (AMPE)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2021-12-294Dicerna Pharmaceuticals Inc (DRNA)Code (U): 4,666 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · +1 moreEDGAR
2021-12-104Benitec Biopharma Inc. (BNTC)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2021-10-254Ampio Pharmaceuticals, Inc. (AMPE)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2021-06-074Dicerna Pharmaceuticals Inc (DRNA)Option exercise (M): 4,666 · Option exercise (M): 4,666 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-05-074Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 46,218 · Grant/award (A): 35,406 (derivative) @ $0 · Option exercise (M): 46,218 (derivative) @ $0EDGAR
2021-05-064ZIOPHARM ONCOLOGY INC (ZIOP)Grant/award (A): 4,167 @ $0 · Grant/award (A): 31,250 (derivative) @ $0EDGAR
2020-12-114Benitec Biopharma Inc. (BNTC)Grant/award (A): 23,601 (derivative) @ $0EDGAR
2020-10-134ZIOPHARM ONCOLOGY INC (ZIOP)Grant/award (A): 146,190 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1209726 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs